FPCP
LLY icon

Fort Point Capital Partners’s Eli Lilly LLY Stock Holding History

Fort Point Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334K Sell
363
-1
-0.3% -$1.01K 0.04% 175
2025
Q4 		$376K Buy
+364
New +$348K 0.04% 171
2025
Q3 		– Sell
-1,114
Closed -$868K – 283
2025
Q2 		$868K Buy
1,114
+40
+4% +$31.1K 0.06% 162
2025
Q1 		$887K Sell
1,074
-44
-4% -$36.6K 0.1% 139
2024
Q4 		$863K Sell
1,118
-54
-5% -$44.7K 0.09% 145
2024
Q3 		$1.04M Buy
1,172
+183
+19% +$165K 0.13% 109
2024
Q2 		$895K Sell
989
-1,504
-60% -$1.2M 0.11% 130
2024
Q1 		$1.94M Sell
2,493
-10
-0.4% -$7.12K 0.26% 69
2023
Q4 		$1.46M Buy
2,503
+5
+0.2% +$2.92K 0.21% 81
2023
Q3 		$1.34M Buy
2,498
+187
+8% +$96.4K 0.2% 79
2023
Q2 		$1.08M Buy
2,311
+55
+2% +$23.1K 0.15% 89
2023
Q1 		$775K Buy
2,256
+25
+1% +$8.43K 0.12% 123
2022
Q4 		$816K Sell
2,231
-27
-1% -$9.57K 0.13% 113
2022
Q3 		$730K Sell
2,258
-2
-0.1% -$634 0.12% 121
2022
Q2 		$733K Sell
2,260
-126
-5% -$37.8K 0.12% 123
2022
Q1 		$683K Buy
2,386
+125
+6% +$32.2K 0.1% 143
2021
Q4 		$625K Sell
2,261
-5
-0.2% -$1.27K 0.08% 136
2021
Q3 		$524K Buy
2,266
+641
+39% +$158K 0.08% 135
2021
Q2 		$373K Buy
1,625
+1
+0.1% +$201 0.07% 123
2021
Q1 		$303K Sell
1,624
-300
-16% -$58.7K 0.07% 127
2020
Q4 		$325K Sell
1,924
-220
-10% -$32.8K 0.07% 114
2020
Q3 		$317K Buy
2,144
+144
+7% +$22.3K 0.08% 103
2020
Q2 		$328K Sell
2,000
-40
-2% -$6.14K 0.1% 96
2020
Q1 		$283K Buy
2,040
+100
+5% +$13.7K 0.12% 81
2019
Q4 		$255K Buy
+1,940
New +$225K 0.09% 111
2019
Q2 		– Sell
-1,568
Closed -$203K – 111
2019
Q1 		$203K Sell
1,568
-995
-39% -$121K 0.09% 104
2018
Q4 		$297K Buy
2,563
+28
+1% +$3.13K 0.12% 112
2018
Q3 		$272K Sell
2,535
-566
-18% -$56.6K 0.08% 128
2018
Q2 		$265K Sell
3,101
-225
-7% -$18.5K 0.09% 106
2018
Q1 		$257K Sell
3,326
-621
-16% -$50K 0.09% 127
2017
Q4 		$333K Buy
+3,947
New +$336K 0.16% 85
2016
Q4 		– Sell
-7,155
Closed -$547K – 132
2016
Q3 		$547K Buy
7,155
+4,000
+127% +$320K 0.25% 71
2016
Q2 		$248K Buy
+3,155
New +$238K 0.12% 97
2016
Q1 		– Sell
-3,354
Closed -$283K – 126
2015
Q4 		$283K Buy
+3,354
New +$278K 0.14% 87
2015
Q3 		– Sell
-2,765
Closed -$231K – 94
2015
Q2 		$231K Buy
+2,765
New +$211K 0.14% 62
2014
Q4 		– Sell
-6,500
Closed -$422K – 70
2014
Q3 		$422K Hold
6,500
– – 0.32% 35
2014
Q2 		$404K Hold
6,500
– – 0.36% 25
2014
Q1 		$381K Buy
+6,500
New +$363K 0.37% 26

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fort Point Capital Partners's LLY Position: Q1 2026 in Review

Fort Point Capital Partners reduced its Eli Lilly (LLY) stake by 0.27% in Q1 2026, selling an estimated $1.01K and leaving 363 shares worth $334K. The position accounts for 0.04% of the portfolio, ranked #175.

Fort Point Capital Partners first reported a position in LLY in Q1 2014 and has held it in 38 quarters since. The position peaked at $1.94M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fort Point Capital Partners held 363 shares of Eli Lilly worth $334K as of Q1 2026.
  • Fort Point Capital Partners sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.04% of Fort Point Capital Partners's portfolio in Q1 2026, its #175 holding.
  • Fort Point Capital Partners first reported a position in Eli Lilly in Q1 2014 and has held it in 38 quarters since.
  • Fort Point Capital Partners's Eli Lilly position peaked at $1.94M in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fort Point Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.